Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Itraconazole may cause low platelet and white blood cell counts.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

PTH-CBD agonists may help regrow hair after chemotherapy.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Liposomal IGF-1 safely and effectively treats hair loss in hamsters.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Hypaphorine from a fungus changes the internal structure of Eucalyptus root hairs, stopping their growth.

A girl with a rare skin condition improved after one month of treatment with acitretin.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

GI197111X is best dissolved in Capmul MCM for trials.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.